| |
|
|
| Sunday, April 18, 2010 |
|
|
 |
| Welcoming Remarks |
|
|
Leroy Hood, MD, PhD,
Co-founder and President, Institute for Systems Biology
|
|
Windows |
|
| Opening Keynote Address |
|
|
Alan Aderem, PhD,
Co-founder and Director,
Institute for Systems Biology
|
|
|
|
|
| SESSION I VACCINES |
|
|
Bali Pulendran, PhD,
Emory University Vaccine Center
|
|
|
|
Rafick-Pierre Sékaly, PhD,
Vaccine and Gene Therapy Institute Florida
University of Montreal
|
|
|
|
Paul de Bakker, PhD,
Brigham and Women´s Hospital
Harvard Medical School
The Broad Institute
|
|
|
|
|
Session 1 Speaker Panel
|
|
|
|
Monday, April 19, 2010 |
|
|
|
|
SESSION II INFECTIOUS AGENTS
|
|
|
Clifton E. Barry, III, PhD,
National Institute of Allergy and Infectious Disease
|
|
Windows |
|
David Sherman, PhD,
Seattle Biomedical Research Institute
|
|
Windows |
|
Douglas B. Young, PhD,
Imperial College London
UK National Institute for Medical Research
|
|
|
|
Jay Keasling, Phd
University of California, Berkeley |
|
Windows |
|
Session 2 Speaker Panel,
|
|
Windows |
|
|
SESSION III TECHNOLOGY
|
|
|
Michael P. Rout, PhD,
The Rockefeller University
|
|
|
|
Stephen R. Quake, PhD,
Stanford University
|
|
Windows |
|
William Schief, PhD,
University of Washington
|
|
|
|
| Session 3 Speaker Panel |
|
Windows |
|
|
SYMPOSIUM CLOSING
|
|
|
Closing Keynote Address
Peter Small, MD
Senior Program Officer, Bill and Melinda Gates Foundation
|
|
|
|
|
|
Windows |
|
Closing Remarks
John Aitchison, PhD
Associate Director and Professor, Institute for Systems Biology |
|
|
|
|
|
|
|
home
